Overview
- 6 FDA inspections are on record.
- 3 inspections produced a Form 483.
- The most recent recorded inspection date is 2026-05-07.
At a glance
Inspections
6
Form 483s
3
EIRs
0
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 22 Apr 2026 – 7 May 2026 | Human Drugs | 483 | View 483 → |
| 28 Jun 2022 – 30 Jun 2022 | Human Drugs | 483 | On file |
| 6 Jun 2019 | Foods & Cosmetics | Clean | |
| 23 Jun 2016 – 7 Jul 2016 | Human Drugs | Clean | |
| 18 Jan 2011 | Not recorded | 483 | View 483 → |
| 8 Mar 2007 | Not recorded | Clean |
Observations on record
Form 483 observations cited at this site, most recent first.
Absence of Written Procedures
Cited by Gabriel Bermudez-Picart, Angela C Welker, Scott D Mcgrew, Chikitsa S Patel
Scientifically sound laboratory controls
Cited by Gabriel Bermudez-Picart, Angela C Welker, Scott D Mcgrew, Chikitsa S Patel
Testing and release for distribution
Cited by Gabriel Bermudez-Picart, Angela C Welker, Scott D Mcgrew, Chikitsa S Patel
Items to cover on annual reviews
Cited by Gabriel Bermudez-Picart, Angela C Welker, Scott D Mcgrew, Chikitsa S Patel
Prepared for each batch, include complete information
Cited by Gabriel Bermudez-Picart, Angela C Welker, Scott D Mcgrew, Chikitsa S Patel
Investigators
FDA investigators tied to this site in the record.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.160(b) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.100(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.100(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.110(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.165(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.180(e)(2) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.188 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.22(c) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.42(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.63 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.67(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.67(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.80(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.84(d)(2) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Topical Pharmaceuticals, Inc.'s 3 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat